← Browse by Condition
Medical Condition

chronic insomnia

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for chronic insomnia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chronic insomnia Clinical Trials

How many clinical trials are currently recruiting for chronic insomnia?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for chronic insomnia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic insomnia?
chronic insomnia research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic insomnia clinical trial?
Eligibility criteria for chronic insomnia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Salem Anaesthesia Pain Clinic 1 trial
University of Pennsylvania 1 trial
Xuanwu Hospital, Beijing 1 trial
University of Notre Dame 1 trial

Recruiting Clinical Trials

NCT05618002
Recruiting
Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Enrollment
150 pts
Location
Canada
Sponsor
Salem Anaesthesia Pain Clinic
View Trial →
NCT07542756 Phase 4
Recruiting
A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
Enrollment
1,200 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06658184
Recruiting
Effects of Sleep Restriction and Stimulus Control in Chronic Insomnia Patients
Enrollment
88 pts
Location
China
Sponsor
Xuanwu Hospital, Beijing
View Trial →
NCT07156383
Recruiting
Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study
Enrollment
115 pts
Location
United States
Sponsor
University of Notre Dame
View Trial →

Related Conditions

chronic pain (1) insomnia (1) insomnia disorder (1) chronic insomnia disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology